FOXG1 Syndrome clinical trials at University of California Health

1 in progress, 0 open to eligible people

FRF-001, an AAV-9 Gene Therapy, in Patients With FOXG1 Syndrome (FS)
Sorry, accepting new patients by invitation only
The goal of this clinical trial is to learn if FRF-001 is a safe, tolerable, and efficacious treatment for children and adults with FOXG1 syndrome.
at UCSF

Last updated: October 12, 2026